BCI
PFE icon

Blue Capital Inc’s Pfizer PFE Stock Holding History

Blue Capital Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
11,600
+1,866
+19% +$48.8K 0.18% 100
2026
Q1 		$273K Buy
9,734
+1,068
+12% +$28.4K 0.18% 88
2025
Q4 		$216K Buy
+8,666
New +$219K 0.15% 83
2024
Q4 		$595K Buy
+22,444
New +$609K 0.42% 66

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Blue Capital Inc's PFE Position: Q2 2026 in Review

Blue Capital Inc increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $48.8K and bringing the position to 11,600 shares worth $279K. The position accounts for 0.18% of the portfolio, ranked #100.

Blue Capital Inc first reported a position in PFE in Q4 2024 and has held it in 4 quarters since. The position peaked at $595K in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Blue Capital Inc held 11,600 shares of Pfizer worth $279K as of Q2 2026.
  • Blue Capital Inc bought 1,866 Pfizer shares in Q2 2026, an estimated $48.8K.
  • Pfizer made up 0.18% of Blue Capital Inc's portfolio in Q2 2026, its #100 holding.
  • Blue Capital Inc first reported a position in Pfizer in Q4 2024 and has held it in 4 quarters since.
  • Blue Capital Inc's Pfizer position peaked at $595K in Q4 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Blue Capital Inc's 13F filing for Q2 2026, filed 11 Aug 2026.